| Name | 1-(2,6-dihydroxyphenyl)-9-(4-hydroxyphenyl)nonan-1-one | 
|---|---|
| Synonyms | malabricone B Malabaricon B malabaricone B | 
| Description | Malabaricone B, a naturally occurring plant phenolic, is an orally active α-glucosidase inhibitor with an IC50 of 63.7 µM. Malabaricone B has anticancer, antimicrobial, anti-oxidation and antidiabetic activities[1][2][3]. | 
|---|---|
| Related Catalog | |
| In Vitro | Malabaricone B shows selective toxicity to human lung cancer (A549), malignant melanoma (A375) and T cell leukemia (Jurkat) cell lines, without showing toxicity to human normal intestinal (INT407), human kidney (HEK293) and lung fibroblast (WI-38) cells. Among the chosen cancer cell lines, Malabaricone B shows maximum cytotoxicity to the A549 cells (IC50 = 8.1 μM), which is significantly better than that of curcumin (IC50 = 26.7 μM)[1]. The Malabaricone B-induced apoptosis is mediated by an increase in the intracellular reactive oxygen species (ROS). Malabaricone B (2.5, 5, 10 and 20 µM) increases the BAX level while simultaneously decreasing the BCL-2 and BCL-XL levels in the A549 cells, triggering the mitochondrial apoptotic pathway as revealed from the release of cytochrome c, and the activation of caspase-9 and caspase-3[1]. Malabaricone B exhibits a good level of antimicrobial activity when tested against avariety of microorganisms, including Staphylococcus aureus and Candida albicans[2]. | 
| In Vivo | Malabaricone B (100 mg/kg; p.o; alternate day, 23 days) inhibits lung tumor (xenograft) growth in SCID mice[1]. | 
| References | 
| Density | 1.17g/cm3 | 
|---|---|
| Boiling Point | 536.4ºC at 760 mmHg | 
| Molecular Formula | C21H26O4 | 
| Molecular Weight | 342.43 | 
| Flash Point | 292.3ºC | 
| Exact Mass | 342.18300 | 
| PSA | 77.76000 | 
| LogP | 4.95950 | 
| Index of Refraction | 1.59 | 
| Precursor 4 | |
|---|---|
| DownStream 0 | |